Skip to content
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
Scopus BioPharma Completes Recapitalization Designed to Enhance Shareholder Value (10.18.22) FINAL
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
  • Contact
  • Contact

About

  • Overview
  • Team Background
  • Public Healthcare
  • Overview
  • Team Background
  • Public Healthcare

Team

  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Senior Advisors
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Senior Advisors

Programs

  • Overview
  • Pipeline
  • Strategic Partners
  • Drug Candidates
  • CO-sTiRNA™
  • MRI-1867
  • Additional R&D Programs
  • Scientific Publications
  • Overview
  • Pipeline
  • Strategic Partners
  • Drug Candidates
  • CO-sTiRNA™
  • MRI-1867
  • Additional R&D Programs
  • Scientific Publications

Media

  • Media
  • Media

News and Events

  • Press Releases
  • News
  • Events
  • Presentations
  • Press Releases
  • News
  • Events
  • Presentations

Investors

  • Company Information
  • News and Events
  • Presentations
  • SEC Filings
  • Corporate Governance
  • Stock Data
  • Research Coverage
  • Company Information
  • News and Events
  • Presentations
  • SEC Filings
  • Corporate Governance
  • Stock Data
  • Research Coverage
  • Contact
  • Contact

© 2023 Scopus BioPharma. All rights reserved | Privacy Policy | Cookies Policy